Repression of the major immediate early promoter of human cytomegalovirus allows transcription from an alternate promoter. 2023

Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
Institute of Immunity & Transplantation, Royal Free Campus, Division of Infection & Immunity, UCL, London, UK.

Following infection, the human cytomegalovirus (HCMV) genome becomes rapidly associated with host histones which can contribute to the regulation of viral gene expression. This can be seen clearly during HCMV latency where silencing of the major immediate early promoter (MIEP), normally responsible for expression of the key lytic proteins IE72 and IE86, is mediated by histone methylation and recruitment of heterochromatin protein 1. Crucially, reversal of these histone modifications coupled with histone acetylation drives viral reactivation which can be blocked with specific histone acetyltransferase inhibitors (HATi). In lytic infection, a role for HATi is less clear despite the well-established enhancement of viral replication observed with histone deacetylase inhibitors. Here we report that a number of different broad-acting HATi have a minor impact on viral infection and replication during lytic infection with the more overt phenotypes observed at lower multiplicities of infection. However, specific analyses of the regulation of major immediate early (MIE) gene expression reveal that the HATi C646, which targets p300/CBP, transiently repressed MIE gene expression via inhibition of the MIEP but by 24 h post-infection MIE gene expression was rescued due to compensatory activation of an alternative IE promoter, ip2. This suggested that silencing of the MIEP promoted alternative ip2 promoter activity in lytic infection and, consistent with this, ip2 transcription is impaired in cells infected with a recombinant HCMV that does not auto-repress the MIEP at late times of infection. Furthermore, inhibition of the histone methyltransferases known to be responsible for auto-repression is similarly inhibitory to ip2 transcription in wild-type infected cells. We also observe that these discrete transcriptional activities of the MIEP and ip2 promoter are also reflected in reactivation; essentially in cells where the MIEP is silenced, ip2 activity is easier to detect at very early times post-reactivation whereas in cells where robust activation of the MIEP is observed ip2 transcription is reduced or delayed. Finally, we observe that inhibition of pathways demonstrated to be important for reactivation of HCMV in dendritic cells, e.g. in response to IL-6, are preferentially important for activation of the MIEP and not the ip2 promoter. Together, these data add to the hypothesis that the existence of multiple promoters within the MIE region of HCMV can drive reactivation in a cell type- and ligand-specific manner and also suggest that inter-dependent regulatory activity between the two promoters exists.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017781 Genes, Immediate-Early Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters. Immediate Early Gene,Immediate-Early Gene,Immediate-Early Genes,Early Gene, Immediate,Early Genes, Immediate,Gene, Immediate Early,Gene, Immediate-Early,Genes, Immediate Early,Immediate Early Genes

Related Publications

Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
June 2013, Viruses,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
June 2009, Journal of immunology (Baltimore, Md. : 1950),
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
January 1993, Proceedings of the National Academy of Sciences of the United States of America,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
September 2008, Virology,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
February 1984, Proceedings of the National Academy of Sciences of the United States of America,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
June 2020, The Journal of general virology,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
March 1988, Journal of virology,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
December 2006, The Journal of biological chemistry,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
July 1990, Journal of virology,
Rebecca Mason, and Eleanor Bradley, and Mark Wills, and John Sinclair, and Matthew Reeves
July 1994, Nucleic acids research,
Copied contents to your clipboard!